Status:
COMPLETED
Serum Regucalcin Level and Chronic Hepatitis B
Lead Sponsor:
Konya Meram State Hospital
Conditions:
Chronic Hepatitis b
Liver Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study, it was aimed to investigate the relationship between serum regucalcin level and liver fibrosis level in patients with CHB infection.
Detailed Description
Chronic hepatitis B (CHB) infection continues to be an important health problem due to its high morbidity and mortality. For this reason, it is very important to determine the appropriate timing to st...
Eligibility Criteria
Inclusion
- Being followed up with a diagnosis of chronic hepatitis B
- Not having a known history of liver disease who applied to our outpatient clinic for other reasons
- Having a liver biopsy
- ≥18 years
Exclusion
- \<18 years
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05435599
Start Date
August 1 2020
End Date
December 1 2021
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konya Training and Research Hospital
Konya, Turkey (Türkiye), 42090